Toutes les études
RecrutementPHASE3INTERVENTIONNEL

Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)

The IMPEDE-PKD study is investigating if a common diabetes medication called metformin could help people with a specific kidney condition called Autosomal Dominant Polycystic Kidney Disease (ADPKD). ADPKD causes cysts to grow in the kidneys, leading to a decline in kidney function over time. Researchers want to see if metformin can slow this decline, improve overall health, and increase quality of life. Currently, treatment options are limited and can have side effects or be expensive. Metformin is an affordable and well-known drug that has shown promise in earlier studies by targeting the way these cysts grow. This large, international study hopes to find a new, effective treatment for ADPKD.

En un coup d'œil

Statut
Recrutement
Phase
PHASE3
Sponsor
The University of Queensland
Objectif d'inscription
1,174
Démarrer
29 nov. 2022
Achèvement estimé
01 Dec 2030

De quoi parle cette étude ?

This study, called IMPEDE-PKD, is looking into a new way to help people with a condition called Autosomal Dominant Polycystic Kidney Disease, or ADPKD. ADPKD is a genetic condition where fluid-filled sacs, called cysts, grow in the kidneys. Over time, these cysts can get bigger and lead to pain, high blood pressure, and eventually, the kidneys not working as well as they should. ADPKD affects many people worldwide and can also lead to other health issues like anxiety and depression.

Currently, there aren't many widely available and affordable treatments for ADPKD. There is one medication approved, but it can have side effects and be expensive. This is where the medication metformin comes in. Metformin is already widely used and trusted to treat type 2 diabetes. However, earlier research has suggested that it might also have properties that could slow down the growth of these kidney cysts in people with ADPKD. If successful, metformin could become a much-needed, affordable, and effective treatment.

This study aims to find out if taking metformin can slow down how quickly kidney function declines in people with ADPKD. If it works, it could significantly reduce serious health problems, improve how long people live, and greatly boost their quality of life. This is a large, international study, and the results could make a big difference for many families affected by ADPKD.

Points clés

  • The study explores if metformin can slow ADPKD progression.
  • ADPKD is a genetic kidney disease causing cysts.
  • Metformin is a common, affordable diabetes drug being re-purposed.
  • The goal is to improve quality of life and reduce health problems for ADPKD patients.
  • Participants will be randomly assigned to metformin or a placebo.
  • This is a large, international study that could lead to new treatments.

Qui peut être éligible ?

In general, this study is looking for adults aged 18 to 70 who have been diagnosed with Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Your kidneys need to be working within a certain range – not too healthy, but not too far along in the disease – to be considered. The doctors will also look at whether your ADPKD shows signs of progressing, either because your kidneys are a certain size, or if your kidney function has been declining over time. They will use specific measurements to figure this out.

However, you won't be able to join if you have diabetes, very high blood pressure that isn't under control, certain serious heart problems, or some types of liver disease. Your doctor will be able to check all these details to see if this study could be right for you.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Avez-vous entre 18 et 70 ans ?
  2. Have you been diagnosed with ADPKD?
  3. Do you have a certain level of kidney function (not too early, not too late stage)?
  4. Are there signs that your ADPKD is progressing, or are your kidneys a certain size?
  5. Do you have diabetes, uncontrolled high blood pressure, or significant heart or liver disease (which would exclude you)?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

Taking part in this study means you would be randomly assigned to either receive the study medication (metformin) or a placebo (a dummy pill that looks like the real medication but has no active ingredients). This is to fairly compare if metformin is effective. You will have regular visits to the clinic for check-ups, blood tests, and scans to monitor your kidney function and overall health. You'll need to take the study medication as instructed. The total duration of your participation in the study, including all follow-up appointments, will be explained by the study team, but typically clinical trials involve multiple visits over several years.

Risques et avantages potentiels

Participating in this study might offer the potential benefit of slowing down the progression of your kidney disease, which could improve your long-term health and quality of life. However, as with any medication, there's a possibility of side effects from metformin, which the study team will explain in detail. There's also the chance the treatment might not be effective for you. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Emplacements (49)

  • Renal Research
    Code postal vérifié
    Gosford, Australia· Actif, mais pas en recrutement
  • Royal Prince Alfred Hospital
    Code postal vérifié
    Sydney, Australie· Actif, mais pas en recrutement
  • Royal North Shore Hospital
    Code postal vérifié
    Sydney, Australie· Actif, mais pas en recrutement
  • Westmead Hospital - Western Sydney Local Health District
    Code postal vérifié
    Sydney, Australie· Actif, mais pas en recrutement
  • Bundaberg Hospital
    Code postal vérifié
    Bundaberg, Australia· Actif, mais pas en recrutement
  • Townsville University Hospital
    Code postal vérifié
    Douglas, Australia· Actif, mais pas en recrutement
  • Royal Brisbane and Women's Hospital
    Code postal vérifié
    Herston, Australia· Actif, mais pas en recrutement
  • Princess Alexandra Hospital
    Code postal vérifié
    Woolloongabba, Australia· Actif, mais pas en recrutement
  • Royal Adelaide Hospital
    Code postal vérifié
    Adelaide, Australia· Actif, mais pas en recrutement
  • Royal Melbourne Hospital
    Code postal vérifié
    Melbourne, Australie· Actif, mais pas en recrutement
  • Austin Health
    Code postal vérifié
    Melbourne, Australie· Actif, mais pas en recrutement
  • Monash Medical Centre
    Code postal vérifié
    Melbourne, Australie· Actif, mais pas en recrutement

Questions fréquentes

What is ADPKD?

ADPKD stands for Autosomal Dominant Polycystic Kidney Disease. It's a genetic condition where fluid-filled sacs, called cysts, grow in your kidneys, which can make them less effective over time.

What is metformin?

Metformin is a common and affordable medication primarily used to treat type 2 diabetes. This study wants to see if it can also help people with ADPKD.

Will I definitely get metformin if I join?

No, you might receive metformin or a placebo (a dummy pill) as part of a randomised study. This helps researchers fairly compare its effects.

Combien de temps durera l'étude ?

The study will involve regular visits and taking medication over a period that will be explained to you by the study team. Clinical trials often last several years.

Can I stop being part of the study whenever I want?

Yes, you can choose to leave the study at any time, for any reason. Your decision won't affect your regular medical care.

Comment en savoir plus

Misa Matsuyama, PhD

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "Implementation of Metformin theraPy to Ease Decline of Kidne… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.